RT Journal Article
SR Electronic
T1 Nonhormone therapies for vasomotor symptom management
JF Cleveland Clinic Journal of Medicine
JO Cleve Clin J Med
FD Cleveland Clinic
SP 237
OP 244
DO 10.3949/ccjm.91a.23067
VO 91
IS 4
A1 Iyer, Tara K.
A1 Fiffick, Alexa N.
A1 Batur, Pelin
YR 2024
UL http://www.ccjm.org/content/91/4/237.abstract
AB Vasomotor symptoms (VMS) are associated with adverse health consequences and can cause significant morbidity for postmenopausal women. Although hormone therapy remains the gold standard of VMS treatment in menopausal women, some women have contraindications to or may choose not to take hormone therapy. This article provides an up-to-date overview of the current evidence-based nonhormone therapies available for managing VMS. Evidence supporting various treatment options is reviewed, including lifestyle interventions, mind-body therapies, procedures, pharmacologic agents, and emerging therapies, such as neurokinin-receptor antagonists. The efficacy, safety, and clinical use of these treatments are detailed, offering insights for clinicians to make informed decisions in menopausal VMS management.